The variant is called EG.5 and is a descendant of Omicron.

The Center for Disease Control and Prevention estimated that EG.5 accounted for roughly 17.3 per cent — or one in six — of new COVID-19 cases in the U.S. in the past two weeks.

  • mranachi@aussie.zone
    ·
    1 year ago

    The best informed benefit/risk of subsequnt boostes is cohort based.

    https://www.health.gov.au/news/atagi-2023-booster-advice

    If you are unsure what's the best choice for you, you should chat with your doctor.